Rituximab in the Management of a Child with Pemphigus Vulgaris: Case Study
Background. Pemphigus vulgaris is an autoimmune bullous dermatosis. Its management generally involves lifelong administration of maintenance dose of systemic glucocorticosteroids, that leading to serious adverse effects especially in children.Clinical case description. Patient is the 16 years old bo...
Saved in:
| Main Authors: | Nikolay N. Murashkin, Leonid A. Opryatin, Anastasiya A. Vasilenko, Eduard T. Ambarchian, Roman V. Epishev, Alexander I. Materikin, Roman A. Ivanov |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
"Paediatrician" Publishers LLC
2022-11-01
|
| Series: | Вопросы современной педиатрии |
| Subjects: | |
| Online Access: | https://vsp.spr-journal.ru/jour/article/view/3037 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Low Dose Vs Conventional Rituximab Regimen in Pemphigus Vulgaris – A Retrospective Single Centre Comparative Analysis to Assess the Clinical Efficacy and Cost-Effectiveness
by: Amuthavalli Kanagarajan, et al.
Published: (2025-07-01) -
The efficacy and safety of low-dose rituximab in the treatment of pemphigus vulgaris: a cohort study
by: Xingli Zhou, et al.
Published: (2024-12-01) -
Assessment of Efficacy of Adjuvant Topical Rituximab Encapsulated in Nanoparticle Gel in Oral Pemphigus Vulgaris: A Randomized, Double-Blind, Placebo-Controlled, Pilot Study
by: Pratik Rajendra Mohta, et al.
Published: (2025-07-01) -
Effectiveness of rituximab in the treatment of patients with pemphigus vulgarus
by: Arfenya E. Karamova, et al.
Published: (2024-11-01) -
Erythema multiforme secondary to filgrastim in a case of pemphigus vulgaris
by: Prachi Bhandare, et al.
Published: (2025-01-01)